Adsorptive Depletion of CD14+CD16+ Proinflammatory Monocyte Phenotype in Patients With Generalized Pustular Psoriasis: Clinical Efficacy and Effects on Cytokines

• Published in: Therapeutic apheresis and dialysis Vol. 16; no. 5; pp. 436 - 444
• Main Authors: Fujisawa, Tomomi, Murase, Kana, Kanoh, Hiroyuki, Takemura, Masao, Ohnishi, Hidenori, Seishima, Mariko
• Format: Journal Article
• Language: English
• Published: Melbourne, Australia Blackwell Publishing Asia 01.10.2012
• Subjects: Adsorptive granulocyte and monocyte apheresis; Adult; CD14+CD16+ proinflammatory monocytes; Chemokines - blood; Chemokines - metabolism; Cytokine; Cytokines - blood; Cytokines - metabolism; Female; Granulocytes - immunology; Humans; Leukapheresis - methods; Lipopolysaccharide Receptors - immunology; Male; Middle Aged; Monocytes - immunology; Neutrophils; Neutrophils - immunology; Psoriasis - immunology; Psoriasis - pathology; Psoriasis - therapy; Pustular psoriasis; Receptors, IgG - immunology; Treatment Outcome
• ISSN: 1744-9979; 1744-9987
• DOI: 10.1111/j.1744-9987.2012.01108.x

Generalized pustular psoriasis (GPP) is a subtype of psoriasis with strong association with activated neutrophils. Adsorptive granulocyte and monocyte apheresis (GMA) is an extracorporeal intervention for selective depletion of activated granulocytes and monocytes. However, the immunological mechanism(s) for the effect of GMA on patients is not fully defined yet. We investigated the effects of GMA on the ratio of CD14+CD16+ proinflammatory monocytes/CD14+ monocytes and cytokine/chemokine production by these leukocytes including CXCL8, CCL2, CCL3, CCL4, CCL5 and tumor necrosis factor (TNF)‐α in five patients with active GPP. CD14+CD16+ monocytes were significantly elevated in patients with active GPP, and GMA markedly reduced the CD14+CD16+/CD14+ ratio together with improvement of patients' clinical symptoms. The serum levels of CXCL8, CCL3 and CCL4 were increased in active GPP patients. Likewise, CCL2 production from monocytes was increased in active GPP patients. Further, CCL3 and CCL4 production from monocytes in active GPP patients were reduced after a course of GMA. Serum CCL5 level and the release of CCL5 from monocytes in active GPP were significantly reduced, but TNF‐α level in active GPP was similar to controls. Based on these results, we believe that in addition to neutrophils, elevated CD14+CD16+ proinflammatory monocytes are part of the immune pathology in GPP. Accordingly, selective depletion of CD14+CD16+ monocytes by GMA should be therapeutic in this condition.